Universidad de Zaragoza-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2024

  1. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis

    Menopause (New York, N.Y.), Vol. 31, Núm. 3, pp. 234-242

2022

  1. Etiopathogenesis of ovarian cancer. An inflamm-aging entity?

    Gynecologic Oncology Reports, Vol. 42